| Target Price | $10.71 |
| Price | $6.71 |
| Potential |
59.61%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Organon & Co. 2026 .
The average Organon & Co. target price is $10.71.
This is
59.61%
register free of charge
$16.80
150.37%
register free of charge
$5.05
24.74%
register free of charge
|
|
| A rating was issued by 15 analysts: 1 Analysts recommend Organon & Co. to buy, 5 to hold and 9 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Organon & Co. stock has an average upside potential 2026 of
59.61%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 6.40 | 6.35 |
| 2.24% | 0.80% | |
| EBITDA Margin | 27.21% | 31.30% |
| 10.07% | 15.05% | |
| Net Margin | 13.49% | 15.91% |
| 17.39% | 17.91% |
8 Analysts have issued a sales forecast Organon & Co. 2025 . The average Organon & Co. sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Organon & Co. EBITDA forecast 2025. The average Organon & Co. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Organon & Co. Analysts have issued a net profit forecast 2025. The average Organon & Co. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.33 | 3.89 |
| 16.54% | 16.82% | |
| P/E | 1.73 | |
| EV/Sales | 1.58 |
7 Analysts have issued a Organon & Co. forecast for earnings per share. The average Organon & Co. EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | May 15 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | May 05 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Sep 06 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
May 15 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
May 05 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 14 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Feb 14 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 06 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


